← Open Payments lookup

JOANNA BEITZEL: Open Payments

NPI 1417638065 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,810 in 58 payments from 13 companies in 2025. Trend: 2023 $104 · 2024 $660 · 2025 $1,810

Food & beverage: $1,810
CompanyPaymentsAmount
Janssen Biotech, Inc.10$649
ABBVIE INC.15$372
Madrigal Pharmaceuticals9$162
Takeda Pharmaceuticals U.S.A., Inc.7$144
Janssen Scientific Affairs, LLC2$135
Gilead Sciences, Inc.3$69
Phathom Pharmaceuticals, Inc.3$58
Lilly USA, LLC2$57
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$55
Aimmune Therapeutics, Inc.1$35

Products named: TREMFYA, REZDIFFRA, CREON, SKYRIZI, ENTYVIO, LINZESS, RINVOQ, VOQUEZNA.

Industry payments across MD — which companies pay providers there.